A New Jersey bill would shield insurers and producers from regulatory and legal risk for covering cannabis businesses.

Senate Bill No. 4018, introduced on March 19, 2026, by Senator Joseph F. Vitale of District 19 (Middlesex), takes direct aim at the uncertainty that has kept many insurers on the sidelines of the state’s cannabis market. The bill, filed during the 222nd Legislature, would supplement New Jersey’s existing cannabis regulatory framework under P.L.2009, c.307 (C.24:6I-1 et seq.) by carving out specific protections for insurers and insurance producers who choose to do business with cannabis-related companies.

At its core, the bill defines a cannabis-related business broadly – covering anyone involved in cultivating, producing, manufacturing, selling, transporting, displaying, dispensing, distributing, purchasing, or facilitating the purchase of cannabis or cannabis products, so long as the activity is conducted under New Jersey state law.

The protections it proposes are straightforward. State and local government agencies would be barred from prohibiting, penalizing, or otherwise discouraging insurers and insurance producers from writing coverage for cannabis businesses. Agencies could not terminate, cancel, or otherwise limit an insurer’s policies simply because the insurer or insurance producer has engaged in the business of insurance in connection with a cannabis-related business. They also could not pressure an insurer or producer to walk away from a policyholder who happens to own, operate, or work for a cannabis-related business, or downgrade or cancel insurance services on that basis alone.

The bill goes a step further on supervisory actions. Government agencies would not be allowed to take adverse or corrective supervisory action on an insurance policy against a cannabis business, its employees, or its owners solely because of their involvement in the cannabis industry. The same protection would extend to owners and operators of real estate or equipment leased to cannabis businesses – they could not be targeted simply for having a cannabis tenant.

On the liability front, the bill offers a notable shield. Insurers, insurance producers, and their officers, directors, and employees would not be held liable under state law or regulation solely for engaging in the business of insurance, or for further investing any income derived from that business of insurance.

The bill is careful to draw its own boundaries. It does not compel any insurer or producer to write cannabis business. Participation remains voluntary. It also does not interfere with the regulation of the business of insurance pursuant to current law, except as expressly provided in the bill.

If enacted, the law would take effect on the 90th day following enactment.

The bill remains in its introductory stage. It has not yet been voted on or signed into law, and its path through the legislature is still to be determined.

For insurers and producers watching the cannabis space, the proposal represents a clear signal from at least one corner of the New Jersey Senate: if you want to write this business, the state should not stand in your way.